2529. Population pharmacokinetic models for cefepime and enmetazobactam derived from pooled Phase 1 to Phase 3 clinical studies

por Vollmer, Jannik, Belley, Adam, Velicitat, Patrick, Machacek, Matthias
Publicado 2023

Modeling the activation of the alternative complement pathway and its effects on hemolysis in health and disease

por Caruso, Antonello, Vollmer, Jannik, Machacek, Matthias, Kortvely, Elod
Publicado 2020

Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen‐Induced Platelet Aggregation

por Renaud, Lionel, Lebozec, Kristell, Voors‐Pette, Christine, Dogterom, Peter, Billiald, Philippe, Jandrot Perrus, Martine, Pletan, Yannick, Machacek, Matthias
Publicado 2020

Protein Kinase A Governs a RhoA-RhoGDI Protrusion-Retraction Pacemaker in Migrating Cells

por Tkachenko, Eugene, Sabouri-Ghomi, Mohsen, Pertz, Olivier, Kim, Chungho, Gutierrez, Edgar, Machacek, Matthias, Groisman, Alex, Danuser, Gaudenz, Ginsberg, Mark H.
Publicado 2011

Coordination of Rho GTPase activities during cell protrusion

por Machacek, Matthias, Hodgson, Louis, Welch, Christopher, Elliott, Hunter, Pertz, Olivier, Nalbant, Perihan, Abell, Amy, Johnson, Gary L., Hahn, Klaus M., Danuser, Gaudenz
Publicado 2009

Half-life extension and non-human primate pharmacokinetic safety studies of i-body AD-114 targeting human CXCR4

por Griffiths, Katherine, Binder, Uli, McDowell, William, Tommasi, Rita, Frigerio, Mark, Darby, William G., Hosking, Chris G., Renaud, Lionel, Machacek, Matthias, Lloyd, Peter, Skerra, Arne, Foley, Michael
Publicado 2019